Phosphatidylserine Got an FDA Health Claim in 2003. The Disclaimer Is Longer Than the Claim.

The Oasis Health Journal · Submitted July 6, 2026 · 11:20 AM EDT

In 2003, the FDA looked at phosphatidylserine and gave it something dietary supplements almost never get, an actual qualified health claim. Then it wrote a disclaimer so long and so hedged that the claim basically apologizes for existing. That is not a joke, go read it yourself. The label is allowed to say phosphatidylserine 'may reduce the risk of cognitive dysfunction in the elderly.' Then, in the same breath, it has to say the evidence behind that sentence is 'very limited and preliminary' and that the FDA 'concludes that there is little scientific evidence supporting this claim.' It is a compliment followed immediately by 'but I could be wrong about all of it,' printed right on a supplement label.

A Supplement With a Complicated Past

Phosphatidylserine is a phospholipid, one of the fatty molecules that build the membrane around every cell you own, concentrated especially in neurons, where membranes do a lot of the actual work of thinking. The research that got everyone excited, Italian trials from the 1980s and 90s, used phosphatidylserine extracted from cow brains, and it worked reasonably well for older adults with memory complaints. Then bovine spongiform encephalopathy, mad cow disease, showed up, and nobody wanted brain extract from cows anywhere near a supplement capsule again. The industry switched to soy, then mostly to sunflower lecithin. Same molecule, different fatty acids riding along with it, and by most accounts, a noticeably weaker effect in the trials that followed. Your brain does not read ingredient labels. It apparently notices anyway.

The 2025 Trial Nobody Is Printing on a Bottle

The newest data point arrived in November 2025 in Nutrition Journal: 100 mg of sunflower-derived phosphatidylserine a day, in gummy form, given to 209 healthy kids ages 8 to 12, over 12 weeks. This trial is worth your attention because it is recent, well-designed, and refreshingly not run by anyone with a bottle to sell. The result: no meaningful difference between phosphatidylserine and placebo on any primary or secondary cognitive measure. One narrow bright spot showed up, a subgroup of kids who scored below the median at baseline improved on a visuospatial memory task, which the researchers flagged as worth chasing later, not proof of anything yet. There was also, amusingly, one measure where the placebo group made fewer mistakes than the supplement group, though so few kids finished that particular test that it reads more like trivia than data. Nobody got hurt either way. The supplement was safe and well tolerated. It just did not make average kids sharper.

Where the Evidence Actually Holds Up

Healthy kids were never really the target market. Phosphatidylserine's best evidence sits at the other end of life. A 2022 systematic review pooling nine studies and 961 older adults found a real positive effect on memory, specifically in people already showing age-related cognitive decline, at doses of 100 to 300 mg a day for 6 weeks to 6 months. A 2024 trial out of Tianjin, China ran a year-long test in 190 adults with mild cognitive impairment, though it is worth being precise here, the product tested was not phosphatidylserine alone. It combined a modest 31.5 mg dose of PS with omega-3 ALA, ginkgo flavonoids, and B vitamins. That combination group improved on arithmetic, similarity, and short-term memory testing, and the researchers' own mediation analysis pointed to rising omega-3 levels, not the phosphatidylserine, as doing most of the mechanistic work. No adverse effects turned up in either study. Put together, the honest read is this: fairly good evidence for aging brains already slipping a little, especially inside combination formulas, no real evidence yet for sharpening a healthy kid's memory on PS alone, and somewhere in the modest middle for the average healthy adult chasing an edge. That is not an insult. Most supplements would be thrilled with a review that says 'modest at best.'

Shopping For It, Honestly

If you buy phosphatidylserine today, you are almost certainly buying sunflower-derived phosphatidylserine softgels, since soy is a common allergen and bovine sources left the market two decades ago. It often gets paired with omega-3s like DHA, another membrane fat, on the idea that a neuron membrane needs more than one building block to stay flexible. Freshness matters more than people assume with lipid supplements like this one, fats oxidize sitting on a shelf, which is the whole argument for ordering from a source that ships fresh instead of warehousing stock for months. Pair it sensibly with the rest of a brain health lineup rather than expecting one softgel to replace eight hours of sleep, and if memory is the actual goal, the wider memory support shelf has options with a steadier track record across age groups.

This article is educational only, not medical advice; talk to your doctor before starting any new supplement.

Sources

1. The cognitive effects of supplementation with sunflower phosphatidyl serine in healthy children aged 8 to 12 years: a randomized controlled trial, Nutrition Journal (2025)
2. Qualified Health Claims: Letters of Enforcement Discretion, U.S. Food and Drug Administration
3. Effect of phosphatidylserine on cognitive function in the elderly: a systematic review and meta-analysis, Korean Journal of Food Science and Technology (2022)
4. Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: a randomized, double-blind, placebo-controlled trial (2024)
5. Phosphatidylserine, background and source history, Wikipedia